Sort
82,697 grants matching “vaccine development”
Emerging Infections Program
$2,067,971Timothy F. Jones · Tennessee State Department Of Health · U01 · FY2010 · CI
SVEU - OPERATION OF A NONHUMAN PRIMATE BREEDING COLONY
$2,066,824Thomas Patterson · Advanced Bioscience Laboratories, Inc. · N01 · FY2013 · AI
Biodefense/Emerging Infection Vaccine Studies
$2,065,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Biodefense/Emerging Infection Vaccine Studies
$2,065,989Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
SPORE in Breast Cancer
$2,065,692Henry Shelton Earp · Univ Of North Carolina Chapel Hill · P50 · FY2007 · CA
Subcellular protein localization in B. subtilis
$2,065,516Kumaran Ramamurthi · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Functional Omics Core Laboratory
$2,065,495Steven Edward Bosinger · Emory University · N01 · FY2025 · AI
Phase III Study of a Nicotine Vaccine for Smoking Cessation
$2,065,470Paul D Kessler · Nabi Biopharmaceuticals · RC2 · FY2010 · DA
The Military HIV Research Program (MHRP) Clinical Trial Unit
$2,065,103Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2023 · AI
Washington University SPORE in Pancreatic Cancer
$2,065,042David G Denardo · Washington University · P50 · FY2023 · CA
Multivalent display of anthrax toxin inhibitors
$2,064,948Marianne Manchester · Scripps Research Institute, The · P01 · FY2007 · AI
Tulane National Primate Research Center U24 AIDS SPF Breeding Colony Maintenance
$2,064,693Rudolf P Bohm · Tulane University Of Louisiana · U24 · FY2015 · OD
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants
$2,064,580Dixon B Kaufman · University Of Wisconsin-Madison · U01 · FY2014 · AI
Philadelphia HIV Therapeutics and Prevention Clinical Trials Unit
$2,063,841Pablo Tebas · University Of Pennsylvania · UM1 · FY2014 · AI
Molecular Approaches To Antiviral Development For Viral Hepatitis and Other Viral Diseases
$2,063,799T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Therapy, Vaccine and Model Development in Viral Hepatitis and Liver Diseases
$2,063,799T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
University of North Carolina - Chlamydia Vaccine Initiative (UNC-CVI)
$2,063,664Toni Darville · Univ Of North Carolina Chapel Hill · U19 · FY2022 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$2,063,299Bernard Moss · Niaid Extramural Activities · Z01 · FY2007 · AI
University of Wisconsin Prostate SPORE
$2,061,062David F Jarrard · University Of Wisconsin-Madison · P50 · FY2023 · CA
Integrative Immunogen Design and Testing
$2,060,891Erica Ollmann Saphire · Brigham And Women'S Hospital · P01 · FY2023 · AI
Papillomavirus Virion Proteins and Vaccines
$2,060,667John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Integrated CV-N Preclinical Clinical Microbicide Program
$2,060,666Biosyn, Inc. · U19 · FY2003 · AI
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
$2,060,583Jennifer Lapek · Scripps Institution Of Oceanography · N01 · FY2024 · AI
Multivalent display of anthrax toxin inhibitors
$2,060,333Scripps Research Institute · P01 · FY2005 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$2,059,956Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI